HAIKOU CITY, China, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (OTC Bulletin Board: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced it will participate in the following conferences:
-- Rodman & Renshaw Annual Global Investment Conference, held September
9-11, 2009 at the New York Palace Hotel in New York City. Management
is currently scheduled to meet with institutional investors and to
present at 12:30 pm ET on Wednesday, September 9, 2009.
-- Maxim 3rd Annual Growth Conference, held September 29, 2009 at the
Grand Hyatt Hotel in New York City.
Live webcasts will be available via the Company's website at http://www.chinapharmaholdings.com/ . For further details, please contact your respective institutional sales representative.
About China Pharma Holdings, Inc.
China Pharma Holdings, Inc. is a specialty pharmaceutical company with rapidly growing profit that develops, manufactures, and markets treatments for a wide range of high incidence and high mortality conditions in China, including cardiovascular, CNS, infectious, and digestive diseases. The Company's cost-effective, high margin business model is driven by market demand and supported by eight scalable GMP-certified product lines covering the major dosage forms. In addition, the Company has a broad and expanding distribution network across 30 provinces, municipalities and autonomous regions. The Company is registered in Delaware, USA. Hainan Helpson Medical & Biotechnology Co., Ltd. (Helpson), located in Haikou City, Hainan Province, China, is a wholly owned subsidiary of China Pharma Holdings, Inc. For more information about China Pharma Holdings, Inc., please visit
http://www.chinapharmaholdings.com .
For more information, please contact:
China Pharma Holdings, Inc.
Tel: +86-898-6681-1730
Email: hps@chinapharmaholdings.com
ICR, Inc.
Christine Duan
Tel: +1-203-682-8200
